We are living in uncertain times with the recent threat of a global pandemic in our midst. Every business is struggling with how to keep their businesses running while keeping their employees and customers safe.
Johnson & Johnson has announced that its Janssen Pharmaceutical Companies have entered a collaboration with the Beth Israel Deaconess Medical Center (BIDMC) to support the development of a preventive vaccine candidate for COVID-19.
